ArticlePflugers Archiv : European journal of physiology2026
Oestrogen receptors regulate vascular β₁- and β₃-adrenoceptor expression and shape sex-specific adrenergic control of vascular tone.
Article in Pflugers Archiv : European journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sex differences in vascular adrenergic responsiveness contribute to differential regulation of vascular tone. Female vessels exhibit enhanced β-adrenergic relaxation compared with males, but the role of oestrogen receptors in maintaining this phenotype and the capacity of sex hormone exposure to reprogram vascular β-adrenoceptor expression remain incompletely understood. Thoracic aorta and mesenteric arteries from Wistar Kyoto rats were examined following pharmacological oestrogen receptor inhibition or cross-sex hormone treatment. Vascular reactivity was assessed using wire myography, and β₁-, β₂-, and β₃-adrenoceptor mRNA expression was quantified by qPCR. Oestrogen receptor blockade with fulvestrant enhanced norepinephrine-induced vasoconstriction and reduced β-adrenergic relaxation in both conduit and resistance arteries. These functional alterations were accompanied by an approximately 50% reduction in β₁- and β₃-adrenoceptor mRNA expression, whereas β₂ expression remained unchanged. Conversely, oestrogen treatment in males attenuated vasoconstriction, enhanced β-adrenergic relaxation, and increased β₁- and β₃-adrenoceptor expression, while testosterone treatment in females had no effects. Despite pronounced vascular changes, arterial blood pressure remained unaltered. Analysis of human aorta, carotid, iliac, and mammary arteries revealed consistently higher β₁- and β₃-adrenoceptor mRNA expression in women compared with men. Oestrogen receptor inhibition reduces vascular β₁- and β₃-adrenoceptor expression and impairs β-adrenergic vasodilation, thereby shifting adrenergic vascular responses towards enhanced constriction. Conversely, oestrogen exposure reprogrammes the male vascular phenotype towards a female-like β-adrenergic profile. These findings identify an oestrogen receptor-dependent β₁/β₃-adrenoceptor axis as a conserved mechanism underlying sex-specific regulation of vascular tone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.